3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow MaaT Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis MaaT033 - Amyotrophic Lateral Sclerosis, ALS | Phase 1 | Completed | MaaT Pharma | 15 | 2023-06-08 | 2025-06-15 |
| Safety and Tolerability Evaluation of MaaT033 MaaT033 capsule - Hematologic Diseases, Chemotherapy Effect | Phase 1 | Completed | MaaT Pharma | 21 | 2020-10-20 | 2022-04-12 |
| PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients Autologous Fecal Microbiota Transplantation - Leukemia, Myeloid, Acute | Phase 1 / Phase 2 | Completed | MaaT Pharma | 20 | 2016-06-01 | 2020-09-09 |
Amyotrophic Lateral Sclerosis (1) · Hematologic Diseases (1) · Leukemia, Myeloid, Acute (1) · Neurodegenerative Diseases (1)
France (3)
Christian Recher, Pr (1) · Gaelle Bruneteau, MD, PhD (1) · Mohamad Mohty, MD, PhD (1)